Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2023-2029

Page: 109

Published Date: 30 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Central Nervous System (CNS) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).

This report studies the global Central Nervous System (CNS) Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Central Nervous System (CNS) Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Central Nervous System (CNS) Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Central Nervous System (CNS) Drug total market, 2018-2029, (USD Million)
Global Central Nervous System (CNS) Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Central Nervous System (CNS) Drug total market, key domestic companies and share, (USD Million)
Global Central Nervous System (CNS) Drug revenue by player and market share 2018-2023, (USD Million)
Global Central Nervous System (CNS) Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Central Nervous System (CNS) Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Central Nervous System (CNS) Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc, Novartis AG, GSK, Eli Lilly, Teva, Otsuka Pharmaceutical Co., Ltd, Biogen Inc and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Central Nervous System (CNS) Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Central Nervous System (CNS) Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Central Nervous System (CNS) Drug Market, Segmentation by Type
    Prescription Drugs
    OTC

Global Central Nervous System (CNS) Drug Market, Segmentation by Application
    MS Therapeutics
    Antipsychotic Drugs
    Depression Drugs
    Epilepsy Drugs
    Others

Companies Profiled:
    Johnson & Johnson
    Pfizer Inc
    Novartis AG
    GSK
    Eli Lilly
    Teva
    Otsuka Pharmaceutical Co., Ltd
    Biogen Inc
    Boehringer Ingelheim
    Roche
    UCB
    Tekeda
    Shanghai Fosun
    Jiangsu Nhwa Pharmaceutical Co., Ltd.

Key Questions Answered
1. How big is the global Central Nervous System (CNS) Drug market?
2. What is the demand of the global Central Nervous System (CNS) Drug market?
3. What is the year over year growth of the global Central Nervous System (CNS) Drug market?
4. What is the total value of the global Central Nervous System (CNS) Drug market?
5. Who are the major players in the global Central Nervous System (CNS) Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Central Nervous System (CNS) Drug Introduction
    1.2 World Central Nervous System (CNS) Drug Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Central Nervous System (CNS) Drug Total Market by Region (by Headquarter Location)
        1.3.1 World Central Nervous System (CNS) Drug Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Central Nervous System (CNS) Drug Market Size (2018-2029)
        1.3.3 China Central Nervous System (CNS) Drug Market Size (2018-2029)
        1.3.4 Europe Central Nervous System (CNS) Drug Market Size (2018-2029)
        1.3.5 Japan Central Nervous System (CNS) Drug Market Size (2018-2029)
        1.3.6 South Korea Central Nervous System (CNS) Drug Market Size (2018-2029)
        1.3.7 ASEAN Central Nervous System (CNS) Drug Market Size (2018-2029)
        1.3.8 India Central Nervous System (CNS) Drug Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Central Nervous System (CNS) Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Central Nervous System (CNS) Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.2 World Central Nervous System (CNS) Drug Consumption Value by Region
        2.2.1 World Central Nervous System (CNS) Drug Consumption Value by Region (2018-2023)
        2.2.2 World Central Nervous System (CNS) Drug Consumption Value Forecast by Region (2024-2029)
    2.3 United States Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.4 China Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.5 Europe Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.6 Japan Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.7 South Korea Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.8 ASEAN Central Nervous System (CNS) Drug Consumption Value (2018-2029)
    2.9 India Central Nervous System (CNS) Drug Consumption Value (2018-2029)

3 World Central Nervous System (CNS) Drug Companies Competitive Analysis
    3.1 World Central Nervous System (CNS) Drug Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Central Nervous System (CNS) Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Central Nervous System (CNS) Drug in 2022
        3.2.3 Global Concentration Ratios (CR8) for Central Nervous System (CNS) Drug in 2022
    3.3 Central Nervous System (CNS) Drug Company Evaluation Quadrant
    3.4 Central Nervous System (CNS) Drug Market: Overall Company Footprint Analysis
        3.4.1 Central Nervous System (CNS) Drug Market: Region Footprint
        3.4.2 Central Nervous System (CNS) Drug Market: Company Product Type Footprint
        3.4.3 Central Nervous System (CNS) Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Central Nervous System (CNS) Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Central Nervous System (CNS) Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Central Nervous System (CNS) Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Central Nervous System (CNS) Drug Consumption Value Comparison
        4.2.1 United States VS China: Central Nervous System (CNS) Drug Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Central Nervous System (CNS) Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Central Nervous System (CNS) Drug Companies and Market Share, 2018-2023
        4.3.1 United States Based Central Nervous System (CNS) Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Central Nervous System (CNS) Drug Revenue, (2018-2023)
    4.4 China Based Companies Central Nervous System (CNS) Drug Revenue and Market Share, 2018-2023
        4.4.1 China Based Central Nervous System (CNS) Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Central Nervous System (CNS) Drug Revenue, (2018-2023)
    4.5 Rest of World Based Central Nervous System (CNS) Drug Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Central Nervous System (CNS) Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Central Nervous System (CNS) Drug Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Central Nervous System (CNS) Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Prescription Drugs
        5.2.2 OTC
    5.3 Market Segment by Type
        5.3.1 World Central Nervous System (CNS) Drug Market Size by Type (2018-2023)
        5.3.2 World Central Nervous System (CNS) Drug Market Size by Type (2024-2029)
        5.3.3 World Central Nervous System (CNS) Drug Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Central Nervous System (CNS) Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 MS Therapeutics
        6.2.2 Antipsychotic Drugs
        6.2.3 Depression Drugs
        6.2.4 Epilepsy Drugs
        6.2.5 Epilepsy Drugs
    6.3 Market Segment by Application
        6.3.1 World Central Nervous System (CNS) Drug Market Size by Application (2018-2023)
        6.3.2 World Central Nervous System (CNS) Drug Market Size by Application (2024-2029)
        6.3.3 World Central Nervous System (CNS) Drug Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Details
        7.1.2 Johnson & Johnson Major Business
        7.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Product and Services
        7.1.4 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Johnson & Johnson Recent Developments/Updates
        7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.2 Pfizer Inc
        7.2.1 Pfizer Inc Details
        7.2.2 Pfizer Inc Major Business
        7.2.3 Pfizer Inc Central Nervous System (CNS) Drug Product and Services
        7.2.4 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Inc Recent Developments/Updates
        7.2.6 Pfizer Inc Competitive Strengths & Weaknesses
    7.3 Novartis AG
        7.3.1 Novartis AG Details
        7.3.2 Novartis AG Major Business
        7.3.3 Novartis AG Central Nervous System (CNS) Drug Product and Services
        7.3.4 Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Novartis AG Recent Developments/Updates
        7.3.6 Novartis AG Competitive Strengths & Weaknesses
    7.4 GSK
        7.4.1 GSK Details
        7.4.2 GSK Major Business
        7.4.3 GSK Central Nervous System (CNS) Drug Product and Services
        7.4.4 GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 GSK Recent Developments/Updates
        7.4.6 GSK Competitive Strengths & Weaknesses
    7.5 Eli Lilly
        7.5.1 Eli Lilly Details
        7.5.2 Eli Lilly Major Business
        7.5.3 Eli Lilly Central Nervous System (CNS) Drug Product and Services
        7.5.4 Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Eli Lilly Recent Developments/Updates
        7.5.6 Eli Lilly Competitive Strengths & Weaknesses
    7.6 Teva
        7.6.1 Teva Details
        7.6.2 Teva Major Business
        7.6.3 Teva Central Nervous System (CNS) Drug Product and Services
        7.6.4 Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Teva Recent Developments/Updates
        7.6.6 Teva Competitive Strengths & Weaknesses
    7.7 Otsuka Pharmaceutical Co., Ltd
        7.7.1 Otsuka Pharmaceutical Co., Ltd Details
        7.7.2 Otsuka Pharmaceutical Co., Ltd Major Business
        7.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Services
        7.7.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Otsuka Pharmaceutical Co., Ltd Recent Developments/Updates
        7.7.6 Otsuka Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
    7.8 Biogen Inc
        7.8.1 Biogen Inc Details
        7.8.2 Biogen Inc Major Business
        7.8.3 Biogen Inc Central Nervous System (CNS) Drug Product and Services
        7.8.4 Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Biogen Inc Recent Developments/Updates
        7.8.6 Biogen Inc Competitive Strengths & Weaknesses
    7.9 Boehringer Ingelheim
        7.9.1 Boehringer Ingelheim Details
        7.9.2 Boehringer Ingelheim Major Business
        7.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Services
        7.9.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Boehringer Ingelheim Recent Developments/Updates
        7.9.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.10 Roche
        7.10.1 Roche Details
        7.10.2 Roche Major Business
        7.10.3 Roche Central Nervous System (CNS) Drug Product and Services
        7.10.4 Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Roche Recent Developments/Updates
        7.10.6 Roche Competitive Strengths & Weaknesses
    7.11 UCB
        7.11.1 UCB Details
        7.11.2 UCB Major Business
        7.11.3 UCB Central Nervous System (CNS) Drug Product and Services
        7.11.4 UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 UCB Recent Developments/Updates
        7.11.6 UCB Competitive Strengths & Weaknesses
    7.12 Tekeda
        7.12.1 Tekeda Details
        7.12.2 Tekeda Major Business
        7.12.3 Tekeda Central Nervous System (CNS) Drug Product and Services
        7.12.4 Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Tekeda Recent Developments/Updates
        7.12.6 Tekeda Competitive Strengths & Weaknesses
    7.13 Shanghai Fosun
        7.13.1 Shanghai Fosun Details
        7.13.2 Shanghai Fosun Major Business
        7.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Product and Services
        7.13.4 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Shanghai Fosun Recent Developments/Updates
        7.13.6 Shanghai Fosun Competitive Strengths & Weaknesses
    7.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
        7.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Details
        7.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
        7.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Services
        7.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.14.6 Jiangsu Nhwa Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Central Nervous System (CNS) Drug Industry Chain
    8.2 Central Nervous System (CNS) Drug Upstream Analysis
    8.3 Central Nervous System (CNS) Drug Midstream Analysis
    8.4 Central Nervous System (CNS) Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Central Nervous System (CNS) Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Central Nervous System (CNS) Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Central Nervous System (CNS) Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Central Nervous System (CNS) Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Central Nervous System (CNS) Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Central Nervous System (CNS) Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Central Nervous System (CNS) Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Central Nervous System (CNS) Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Central Nervous System (CNS) Drug Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Central Nervous System (CNS) Drug Players in 2022
    Table 12. World Central Nervous System (CNS) Drug Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Central Nervous System (CNS) Drug Company Evaluation Quadrant
    Table 14. Head Office of Key Central Nervous System (CNS) Drug Player
    Table 15. Central Nervous System (CNS) Drug Market: Company Product Type Footprint
    Table 16. Central Nervous System (CNS) Drug Market: Company Product Application Footprint
    Table 17. Central Nervous System (CNS) Drug Mergers & Acquisitions Activity
    Table 18. United States VS China Central Nervous System (CNS) Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Central Nervous System (CNS) Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Central Nervous System (CNS) Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Central Nervous System (CNS) Drug Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Central Nervous System (CNS) Drug Revenue Market Share (2018-2023)
    Table 23. China Based Central Nervous System (CNS) Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Central Nervous System (CNS) Drug Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Central Nervous System (CNS) Drug Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Central Nervous System (CNS) Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Central Nervous System (CNS) Drug Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Central Nervous System (CNS) Drug Revenue Market Share (2018-2023)
    Table 29. World Central Nervous System (CNS) Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Central Nervous System (CNS) Drug Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Central Nervous System (CNS) Drug Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Central Nervous System (CNS) Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Central Nervous System (CNS) Drug Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Central Nervous System (CNS) Drug Market Size by Application (2024-2029) & (USD Million)
    Table 35. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 36. Johnson & Johnson Major Business
    Table 37. Johnson & Johnson Central Nervous System (CNS) Drug Product and Services
    Table 38. Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Johnson & Johnson Recent Developments/Updates
    Table 40. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 41. Pfizer Inc Basic Information, Area Served and Competitors
    Table 42. Pfizer Inc Major Business
    Table 43. Pfizer Inc Central Nervous System (CNS) Drug Product and Services
    Table 44. Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Pfizer Inc Recent Developments/Updates
    Table 46. Pfizer Inc Competitive Strengths & Weaknesses
    Table 47. Novartis AG Basic Information, Area Served and Competitors
    Table 48. Novartis AG Major Business
    Table 49. Novartis AG Central Nervous System (CNS) Drug Product and Services
    Table 50. Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Novartis AG Recent Developments/Updates
    Table 52. Novartis AG Competitive Strengths & Weaknesses
    Table 53. GSK Basic Information, Area Served and Competitors
    Table 54. GSK Major Business
    Table 55. GSK Central Nervous System (CNS) Drug Product and Services
    Table 56. GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. GSK Recent Developments/Updates
    Table 58. GSK Competitive Strengths & Weaknesses
    Table 59. Eli Lilly Basic Information, Area Served and Competitors
    Table 60. Eli Lilly Major Business
    Table 61. Eli Lilly Central Nervous System (CNS) Drug Product and Services
    Table 62. Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Eli Lilly Recent Developments/Updates
    Table 64. Eli Lilly Competitive Strengths & Weaknesses
    Table 65. Teva Basic Information, Area Served and Competitors
    Table 66. Teva Major Business
    Table 67. Teva Central Nervous System (CNS) Drug Product and Services
    Table 68. Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Teva Recent Developments/Updates
    Table 70. Teva Competitive Strengths & Weaknesses
    Table 71. Otsuka Pharmaceutical Co., Ltd Basic Information, Area Served and Competitors
    Table 72. Otsuka Pharmaceutical Co., Ltd Major Business
    Table 73. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Services
    Table 74. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Otsuka Pharmaceutical Co., Ltd Recent Developments/Updates
    Table 76. Otsuka Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
    Table 77. Biogen Inc Basic Information, Area Served and Competitors
    Table 78. Biogen Inc Major Business
    Table 79. Biogen Inc Central Nervous System (CNS) Drug Product and Services
    Table 80. Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Biogen Inc Recent Developments/Updates
    Table 82. Biogen Inc Competitive Strengths & Weaknesses
    Table 83. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 84. Boehringer Ingelheim Major Business
    Table 85. Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Services
    Table 86. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Boehringer Ingelheim Recent Developments/Updates
    Table 88. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 89. Roche Basic Information, Area Served and Competitors
    Table 90. Roche Major Business
    Table 91. Roche Central Nervous System (CNS) Drug Product and Services
    Table 92. Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Roche Recent Developments/Updates
    Table 94. Roche Competitive Strengths & Weaknesses
    Table 95. UCB Basic Information, Area Served and Competitors
    Table 96. UCB Major Business
    Table 97. UCB Central Nervous System (CNS) Drug Product and Services
    Table 98. UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. UCB Recent Developments/Updates
    Table 100. UCB Competitive Strengths & Weaknesses
    Table 101. Tekeda Basic Information, Area Served and Competitors
    Table 102. Tekeda Major Business
    Table 103. Tekeda Central Nervous System (CNS) Drug Product and Services
    Table 104. Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Tekeda Recent Developments/Updates
    Table 106. Tekeda Competitive Strengths & Weaknesses
    Table 107. Shanghai Fosun Basic Information, Area Served and Competitors
    Table 108. Shanghai Fosun Major Business
    Table 109. Shanghai Fosun Central Nervous System (CNS) Drug Product and Services
    Table 110. Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Shanghai Fosun Recent Developments/Updates
    Table 112. Jiangsu Nhwa Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
    Table 113. Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
    Table 114. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Services
    Table 115. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 116. Global Key Players of Central Nervous System (CNS) Drug Upstream (Raw Materials)
    Table 117. Central Nervous System (CNS) Drug Typical Customers
List of Figure
    Figure 1. Central Nervous System (CNS) Drug Picture
    Figure 2. World Central Nervous System (CNS) Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Central Nervous System (CNS) Drug Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Central Nervous System (CNS) Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Central Nervous System (CNS) Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Central Nervous System (CNS) Drug Revenue (2018-2029) & (USD Million)
    Figure 13. Central Nervous System (CNS) Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Central Nervous System (CNS) Drug Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Central Nervous System (CNS) Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Central Nervous System (CNS) Drug by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Central Nervous System (CNS) Drug Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Central Nervous System (CNS) Drug Markets in 2022
    Figure 27. United States VS China: Central Nervous System (CNS) Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Central Nervous System (CNS) Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Central Nervous System (CNS) Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Central Nervous System (CNS) Drug Market Size Market Share by Type in 2022
    Figure 31. Prescription Drugs
    Figure 32. OTC
    Figure 33. World Central Nervous System (CNS) Drug Market Size Market Share by Type (2018-2029)
    Figure 34. World Central Nervous System (CNS) Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Central Nervous System (CNS) Drug Market Size Market Share by Application in 2022
    Figure 36. MS Therapeutics
    Figure 37. Antipsychotic Drugs
    Figure 38. Depression Drugs
    Figure 39. Epilepsy Drugs
    Figure 40. Others
    Figure 41. Central Nervous System (CNS) Drug Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Central Nervous System (CNS) Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Central Nervous System (CNS) Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 11 Jan 2023

date Pharma & Healthcare

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).

Global Central Nervous System (CNS) Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Central Nervous System (CNS) Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Central Nervous System (CNS) Drug market size was valued at USD 119620 million in 2023 and is forecast to a readjusted size of USD 188330 million by 2030 with a CAGR of 6.7% during review period.

Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2024-2030

Global Central Nervous System (CNS) Drug Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Central Nervous System (CNS) Drug market size is expected to reach $ 188330 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

Product Tags

central nervous system cns drug

Central Nervous System (CNS) Drug

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>